stars 1 stars 2 stars 3

Eximore Ltd is an innovative biopharmaceutical company dedicated to the development and commercialization of our proprietary "Pack and Release" punctal plug technology for the treatment of ocular diseases. We are positioned to become a transformative force in the ophthalmic space by revolutionizing drug delivery. Our solutions simplify the complex and burdensome eye drop regimen by offering a non-invasive, sustained-release alternative, addressing a critical need in eye care. With a strategic focus on advancing our glaucoma and dry eye treatments through Phase 2 clinical trials, Eximore is committed to improving patient adherence and compliance. Our goal is to deliver consistent, reliable drug dosing, ultimately ensuring better patient outcomes and redefining the standard of care in ophthalmology.

Eximore Questions

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users